Phio Pharmaceuticals Corp. (PHIO) Q4 2024 Annual Earnings
PHIO·Reported March 31, 2025·Before market open
Phio Pharmaceuticals Corp. reported Q4 2024 revenue of $70.0K. Diluted EPS came in at $-0.85, beat the $-1.23 consensus by $0.38.
Revenue
$70.0K
Diluted EPS
$-0.85beat by $0.38
Consensus: $-1.23
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Phio Pharmaceuticals Corp.'s Q4 2024 earnings report.
Phio Pharmaceuticals Corp. (PHIO) reported Q4 2024 earnings on March 31, 2025 before market open.
Phio Pharmaceuticals Corp. reported revenue of $70.0K and diluted EPS of $-0.85 for Q4 2024.
EPS beat the consensus estimate of $-1.23 by $0.38.
You can read the 10-K periodic report (0001683168-25-002134) directly on SEC EDGAR. The filing index links above go to sec.gov.